EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 79 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,682 | -25.3% | 17,920 | +1.1% | 0.00% | – |
| Q2 2023 | $137,392 | +42.7% | 17,728 | +22.8% | 0.00% | – |
| Q1 2023 | $96,275 | -25.4% | 14,434 | 0.0% | 0.00% | – |
| Q4 2022 | $129,040 | +4.0% | 14,434 | +14.5% | 0.00% | – |
| Q3 2022 | $124,053 | +19.7% | 12,607 | -3.1% | 0.00% | – |
| Q2 2022 | $103,615 | -32.1% | 13,017 | -17.2% | 0.00% | – |
| Q1 2022 | $152,581 | -47.2% | 15,730 | -16.9% | 0.00% | – |
| Q4 2021 | $289,000 | – | 18,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |